Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva

NCT00395499 is registered in ClinicalTrials.gov with Ohio State University as lead sponsor.

NCT NCT00395499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00395499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva
Lead sponsor
Ohio State University
Phase
Observational
Overall status
Completed
Start date
May 31, 2001
Completion date
April 30, 2003
Enrollment
19
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

patients already taking risperidone for clinical indications